326 related articles for article (PubMed ID: 31262498)
1. Predictors of Mortality and Outcomes of Acute Severe Cardiogenic Shock Treated with the Impella Device.
Rohm CL; Gadidov B; Leitson M; Ray HE; Prasad R
Am J Cardiol; 2019 Aug; 124(4):499-504. PubMed ID: 31262498
[TBL] [Abstract][Full Text] [Related]
2. Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device.
Rohm CL; Gadidov B; Ray HE; Mannino SF; Prasad R
Cardiovasc Revasc Med; 2021 Oct; 31():71-75. PubMed ID: 33309042
[TBL] [Abstract][Full Text] [Related]
3. Utilization and Outcomes of Temporary Mechanical Circulatory Support Devices in Cardiogenic Shock.
Enezate T; Eniezat M; Thomas J
Am J Cardiol; 2019 Aug; 124(4):505-510. PubMed ID: 31204034
[TBL] [Abstract][Full Text] [Related]
4. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock.
Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F
J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719
[TBL] [Abstract][Full Text] [Related]
5. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
[TBL] [Abstract][Full Text] [Related]
6. Impella CP use in patients with non-ischaemic cardiogenic shock.
Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
[TBL] [Abstract][Full Text] [Related]
7. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
[TBL] [Abstract][Full Text] [Related]
8. Deploying Mechanical Circulatory Support Via the Axillary Artery in Cardiogenic Shock and High-Risk Percutaneous Coronary Intervention.
Kajy M; Laktineh A; Blank N; Tayal R; Tanveer S; Mohamad T; Elder M; Schreiber T; Kaki A
Am J Cardiol; 2020 Aug; 128():127-133. PubMed ID: 32650906
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Artery Catheter Use and Outcomes in Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock Treated With Impella (a Nationwide Analysis from the United States).
Ismayl M; Hussain Y; Aboeata A; Walters RW; Naidu SS; Messenger JC; Basir MB; Rao SV; Goldsweig AM; Altin SE
Am J Cardiol; 2023 Sep; 203():304-314. PubMed ID: 37517125
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
[TBL] [Abstract][Full Text] [Related]
12. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
[TBL] [Abstract][Full Text] [Related]
13. Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock.
Kuchibhotla S; Esposito ML; Breton C; Pedicini R; Mullin A; O'Kelly R; Anderson M; Morris DL; Batsides G; Ramzy D; Grise M; Pham DT; Kapur NK
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054842
[TBL] [Abstract][Full Text] [Related]
14. Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative.
Basir MB; Kapur NK; Patel K; Salam MA; Schreiber T; Kaki A; Hanson I; Almany S; Timmis S; Dixon S; Kolski B; Todd J; Senter S; Marso S; Lasorda D; Wilkins C; Lalonde T; Attallah A; Larkin T; Dupont A; Marshall J; Patel N; Overly T; Green M; Tehrani B; Truesdell AG; Sharma R; Akhtar Y; McRae T; O'Neill B; Finley J; Rahman A; Foster M; Askari R; Goldsweig A; Martin S; Bharadwaj A; Khuddus M; Caputo C; Korpas D; Cawich I; McAllister D; Blank N; Alraies MC; Fisher R; Khandelwal A; Alaswad K; Lemor A; Johnson T; Hacala M; O'Neill WW;
Catheter Cardiovasc Interv; 2019 Jun; 93(7):1173-1183. PubMed ID: 31025538
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of DanGer shock: Danish-German cardiogenic shock trial.
Udesen NJ; Møller JE; Lindholm MG; Eiskjær H; Schäfer A; Werner N; Holmvang L; Terkelsen CJ; Jensen LO; Junker A; Schmidt H; Wachtell K; Thiele H; Engstrøm T; Hassager C;
Am Heart J; 2019 Aug; 214():60-68. PubMed ID: 31176289
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Impella CP insertion during cardiac arrest: A single center experience.
Kamran H; Batra S; Venesy DM; Patten RD; Waxman S; Pyne C; Shah SP
Resuscitation; 2020 Feb; 147():53-56. PubMed ID: 31891791
[TBL] [Abstract][Full Text] [Related]
18. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.
Casassus F; Corre J; Leroux L; Chevalereau P; Fresselinat A; Seguy B; Calderon J; Coste P; Ouattara A; Roques X; Barandon L
J Interv Cardiol; 2015 Feb; 28(1):41-50. PubMed ID: 25689547
[TBL] [Abstract][Full Text] [Related]
19. Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative.
Basir MB; Lemor A; Gorgis S; Patel KC; Kolski BC; Bharadwaj AS; Todd JW; Tehrani BN; Truesdell AG; Lasorda DM; Lalonde TA; Kaki A; Schrieber TL; Patel NC; Senter SR; Gelormini JL; Marso SP; Rahman AM; Federici RE; Wilkins CE; Thomas McRae A; Nsair A; Caputo CP; Khuddus MA; Chahin JJ; Dupont AG; Goldsweig AM; Lim MJ; Kapur NK; Wohns DHW; Zhou Y; Hacala MJ; O'Neill WW
J Am Heart Assoc; 2023 Dec; 12(23):e031401. PubMed ID: 38014676
[TBL] [Abstract][Full Text] [Related]
20. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
Doshi R; Patel K; Decter D; Jauhar R; Meraj P
Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
